A company that had hoped to be the first to bring an artificial liver device to the U.S. market has suspended its operations. Arbios Systems (Waltham, Massachusetts) said the move is a way to conserve cash while it seeks financing or some relationship to fund clinical trials for its Sepet liver assist device. (Medical Device Daily)